Home   News   Article

Cambridge centre among top two in Europe for cancer research


By Ben Comber


Dr Ferdia Gallagher, Cancer Research UK Clinician Scientist Fellow, Reader in Molecular Imaging, Cambridge Project/Rapid Scanner, Addenbrookes Hospital, Hills Rd, Cambridge, research has involved the translation of hyperpolarized carbon-13 MRI into humans and this has involved creating a bespoke pharmacy facility to assembly the consumables for the clinical hyperpolarizer. Picture: Keith Heppell
Dr Ferdia Gallagher, Cancer Research UK Clinician Scientist Fellow, Reader in Molecular Imaging, Cambridge Project/Rapid Scanner, Addenbrookes Hospital, Hills Rd, Cambridge, research has involved the translation of hyperpolarized carbon-13 MRI into humans and this has involved creating a bespoke pharmacy facility to assembly the consumables for the clinical hyperpolarizer. Picture: Keith Heppell

The Cancer Research UK Cambridge Centre has become the first UK institute to be designated a Comprehensive Cancer Center of Excellence by the European Academy of Cancer Sciences (EACS).

It means Cambridge is one of the top two cancer centres in Europe for outstanding academic research, alongside the Netherlands Cancer Institute.

The Cancer Research UK Cambridge Centre is now the largest CRUK Cancer Centre by funding, totalling approximately £100million a year. More than 600 laboratory and healthcare professionals are based there.

Professor Carlos Caldas, director of the Breast Cancer Programme and lead for European collaborations at the CRUK Cambridge Centre, said: “This new and prestigious designation by the EACS is for us an enormous privilege and also a responsibility. This designation only makes us even more focused in delivering outstanding clinical care for our patients underpinned by the world-class research programmes at the University and CRUK Cambridge Institute.”

Dr Anton Berns, who chairs the EACS committee overseeing the Designation of Excellence process, said: “This is the type of setting that will make a difference for cancer patients and that is precisely why they are so deserving of this prestigious title.

“Clearly, an example for other institutions to follow.”



COMMENTS
()


Iliffe Media does not moderate comments. Please click here for our house rules.

People who post abusive comments about other users or those featured in articles will be banned.

Thank you. Your comment has been received and will appear on the site shortly.

 

Terms of Comments

We do not actively moderate, monitor or edit contributions to the reader comments but we may intervene and take such action as we think necessary, please click here for our house rules.

If you have any concerns over the contents on our site, please either register those concerns using the report abuse button, contact us here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More